Skip to content
JANX Janux Therapeutics, Inc. Common Stock
$14.37 -1.30% -0.19
Notify me if price changes either direction
Interactive Brokers Logotype

Buy JANX stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 878.8M
Enterprise value -45053276
Forward PE -5.2608237
PEG Ratio -5.2608237
Enterprise to EBITDA 0.291
Enterprise to revenue -3.281
Price to book MRQ 0.9431767
Price to sales TTM 64.79005

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2026-03-31
Revenue (TTM) 13.7M
EBITDA -155004000
Diluted EPS TTM -1.84
Total Cash (MRQ) 956.4M
Current ratio (MRQ) 17.008
Operating Cash Flow (TTM) -77548000

JANX trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent JANX News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.